Skip to main content
NCBI home page
British Journal of Experimental Pathology logoLink to British Journal of Experimental Pathology
. 1965 Oct;46(5):564–568.

Studies on copper, caeruloplasmin and cirrhosis in relation to Wilson's disease.

A O Williams
PMCID: PMC2094615  PMID: 5838405

Full text

PDF
564

Images in this article

566-1Figs. 1-2
on p.566-1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEARN A. G., KUNKEL H. G. Metabolic studies in Wilson's disease using Cu64. J Lab Clin Med. 1955 Apr;45(4):623–631. [PubMed] [Google Scholar]
  2. ENGER E. Wilson's disease; report of a case with normal serum ceruloplasmin level. Acta Med Scand. 1959 Feb 25;163(2):121–124. [PubMed] [Google Scholar]
  3. Eden A., Green H. H. Micro-determination of copper in biological material. Biochem J. 1940 Sep;34(8-9):1202–1208. doi: 10.1042/bj0341202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. GERMAN J. L., 3rd, BEARN A. G. Effect of estrogens on copper metabolism in Wilson's disease. J Clin Invest. 1961 Mar;40:445–453. doi: 10.1172/JCI104272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GUBLER C. J., BROWN H., MARKOWITZ H., CARTWRIGHT G. E., WINTROBE M. M. Studies on copper metabolism. XXIII. Portal (Laennec's) cirrhosis of the liver. J Clin Invest. 1957 Aug;36(8):1208–1216. doi: 10.1172/JCI103517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. HEUYER G., BAUDOIN A., AZIMA H., FAURE H., JEROME H., SCHMITT H. A propos de la maladie de Wilson; investigations généalogiques, cliniques, métaboliques portant sur 60 membres d'une famille. Rev Neurol (Paris) 1953;89(3):165–181. [PubMed] [Google Scholar]
  7. HOFFBAUER F. W. Fatty cirrhosis in the rat. I. A method of grading specimens. AMA Arch Pathol. 1959 Aug;68(2):160–170. [PubMed] [Google Scholar]
  8. MUNCH-PETERSEN S. On the copper content in urine in proteinuria. Scand J Clin Lab Invest. 1950;2(4):337–340. doi: 10.3109/00365515009056684. [DOI] [PubMed] [Google Scholar]
  9. O'REILLY S. Observations on ceruloplasmin and methods for its estimation. Neurology. 1961 Mar;11:259–265. doi: 10.1212/wnl.11.3.259. [DOI] [PubMed] [Google Scholar]
  10. OKINAKA S., YOSHIKAWA M., TOYODA M., MOZAI T., TOYOKURA Y., KAMEYAMA M. Pathogenesis of hepatocerebral disease. II. Histochemical study of copper of liver and brain in Wilson's disease. AMA Arch Neurol Psychiatry. 1954 Nov;72(5):573–578. [PubMed] [Google Scholar]
  11. ROSENOER V. M., FRANGLEN G. Caeruloplasmin in Wilson's disease. Lancet. 1959 Dec 26;2(7113):1163–1164. doi: 10.1016/s0140-6736(59)91739-8. [DOI] [PubMed] [Google Scholar]
  12. SASS-KORTSAK A., CHERNIAK M., GEIGER D. W., SLATER R. J. Observations on ceruloplasmin in Wilson's disease. J Clin Invest. 1959 Oct;38:1672–1682. doi: 10.1172/JCI103945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. SCHEINBERG I. H., GITLIN D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). Science. 1952 Oct 31;116(3018):484–485. doi: 10.1126/science.116.3018.484. [DOI] [PubMed] [Google Scholar]
  14. Sternlieb I., Morell A. G., Tucker W. D., Greene M. W., Scheinberg I. H. THE INCORPORATION OF COPPER INTO CERULOPLASMIN IN VIVO: STUDIES WITH COPPER AND COPPER. J Clin Invest. 1961 Oct;40(10):1834–1840. doi: 10.1172/JCI104407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. WALSHE J. M. Treatment of Wilson's disease with penicillamine. Lancet. 1960 Jan 23;1(7117):188–192. doi: 10.1016/s0140-6736(60)90109-4. [DOI] [PubMed] [Google Scholar]
  16. ZIPURSKY A., DEMPSEY H., MARKOWITZ H., CARTWRIGHT G., WINTROBE M. M. Studies on copper metabolism. XXIV. Hypocupremia in infancy. AMA J Dis Child. 1958 Aug;96(2):148–158. doi: 10.1001/archpedi.1958.02060060150004. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Experimental Pathology are provided here courtesy of Wiley

RESOURCES